Export 15 results:
Sort by: Author Title Type [ Year  (Desc)]
Sholkamy, A., and C. 4 contributors, "C4 article: Implications of COVID-19 in transplantation", American J of Transplantation, vol. 21, issue 5, pp. 1801-1815, 2021.
Sholkamy, A., " C4 article: Challenges and solutions to appropriate and timely medication access in transplantation in the United States.", American J of Transplantation, vol. 20, issue 2, pp. 362-376, 2020.
Sholkamy, A., and B. C. C. 4 the to the Article, "Current Opinions in Organ Allocation", Am J Transplant, vol. 2018 Nov;18(11), issue 2018 Nov;18(11), pp. 2625-2634, 2018. Website
AE, H., A. M. A, E. S. M, and et al, "Managing Diabetes and Liver disease association", Arab J Gastroenterol, vol. 2018 Dec;19(4), issue 2018 Dec;19(4), pp. 166-179, 2018. Website
A, S., S. A, E. - G. N, and H. K, "Portal venous pressure and proper graft function in living donor liver transplants in 69 patients from an Egyptian center.", Ann Saudi Med, vol. 2018 May-Jun;38(3), pp. 181-188, 2018. Website
A, D., T. L. Sholkamy A, G. RM, and G. EA, "Transplantation for Hepatocellular Carcinoma: Is There a Tumor Size Limit? ", Transplant Proc., vol. 2018.04.038, 2018. Website
Shiha, G., A. Ibrahim, A. Helmy, S. K. Sarin, M. Omata, A. Kumar, D. Bernstien, H. Maruyama, V. Saraswat, Y. Chawla, et al., "Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.", Hepatology international, issue October 2016, 2016 Oct 6. Abstractapasl_guidelines_2016.pdf

Hepatic fibrosis is a common pathway leading to liver cirrhosis, which is the end result of any injury to the liver. Accurate assessment of the degree of fibrosis is important clinically, especially when treatments aimed at reversing fibrosis are being evolved. Despite the fact that liver biopsy (LB) has been considered the "gold standard" of assessment of hepatic fibrosis, LB is not favored by patients or physicians owing to its invasiveness, limitations, sampling errors, etc. Therefore, many alternative approaches to assess liver fibrosis are gaining more popularity and have assumed great importance, and many data on such approaches are being generated. The Asian Pacific Association for the Study of the Liver (APASL) set up a working party on liver fibrosis in 2007, with a mandate to develop consensus guidelines on various aspects of liver fibrosis relevant to disease patterns and clinical practice in the Asia-Pacific region. The first consensus guidelines of the APASL recommendations on hepatic fibrosis were published in 2009. Due to advances in the field, we present herein the APASL 2016 updated version on invasive and non-invasive assessment of hepatic fibrosis. The process for the development of these consensus guidelines involved review of all available published literature by a core group of experts who subsequently proposed consensus statements followed by discussion of the contentious issues and unanimous approval of the consensus statements. The Oxford System of the evidence-based approach was adopted for developing the consensus statements using the level of evidence from one (highest) to five (lowest) and grade of recommendation from A (strongest) to D (weakest). The topics covered in the guidelines include invasive methods (LB and hepatic venous pressure gradient measurements), blood tests, conventional radiological methods, elastography techniques and cost-effectiveness of hepatic fibrosis assessment methods, in addition to fibrosis assessment in special and rare situations.

Maqsod, A. A., N. Elgarem, K. A. Hosny, O. Abdelaziz, and A. A. salman, "Study of Portal Vein Vascular Hemodynamics in Recepient Patients of Liver Transplantation", 6th Pan Arab Liver Transplant Congress, Cairo Egypt, 16 October, 2015.
Maqsod, A. A., N. Elgarem, I. Fakhry, A. el Kholy, and M. Goda, "Procalcitonin In Diagnosis of Infection in Patients With Liver Cirrhosis", 6th Pan Arab Liver Transplant Congress, Cairo Egypt, 15 October, 2015.
Maqsod, A. A., N. Elgarem, H. Sedrac, and mervat naguib, "OUTCOME PREDICTION FOR CRITICALLY ILL EGYPTIAN CIRRHOTIC PATIENTS IN LIVER INTENSIVE CARE UNIT", 17th Conference of European Society of Organ Transplantation (ESOT), Brussels, 13 Sep 2015.
Sholkamy, A. A., F. gaber, M. Elshazly, and M. Elshafei, "Comparison of Different Scoring Systems in Predicting Short-Term Mortality After Liver Transplantation", transplantation proceedings, vol. 47, pp. 1207-1210, 2015. Website
Khalek, H. A., B. Abass, A. A. Maqsod, and et al, "Managing Diabetes and Liver Disease Association Guidelines (Consensus) Development", journal of endocrinology diabetes and obesity, vol. 3, issue 2, pp. 1073, 2015. liver_diabetes_guidelines.pdfWebsite
Maqsod, A. A., "liver transplantation for non transplant physician", Egyptian j Internal Medicine, vol. 26, pp. 139-144, 2014. Abstractliver_tx_for_non_transplant_physician.pdfWebsite

Many of the nontransplant physicians who manage hepatic patients (internists and hepatologists) keep asking about liver transplantation. The purpose of this article is to highlight important topics a nontransplant colleague may require in his practice. There are many topics in this respect; however, three most important topics need to be highlighted; those are; the time of referral to transplantation, the indications and contraindications and the metabolic issues regarding a transplanted patient. Still, there are no clear guidelines for the management of many of the metabolic issues regarding liver transplanted patients. And this why, collaborative efforts of transplant and nontransplant physicians are needed to conduct multicenter, long term randomized controlled trials and proper follow up programs.

Maqsod, A. A., N. Elgarem, M. El shazly, and ahmad osthman, "New-Onset Diabetes and Hypertension as Complications of Liver Transplantation", Transplantation Proceedings, vol. 46, issue 3, pp. 870-872, 2014. Website
Maqsod, A. A., and A. Zakaria, "hepatic blood flow in late sepsis patients", egyptian j of internal medicine, vol. 25, pp. 15-19, 2013. hepatic_blodd_flow_in_sepsis.pdf